Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Core Viewpoint - Carisma Therapeutics Inc. is actively participating in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference, highlighting its focus on macrophage-focused therapeutics [1] Company Overview - Carisma Therapeutics is a biopharmaceutical company specializing in macrophage engineering to develop innovative therapies for diseases such as fibrosis and cancer [3] - The company is committed to patient-centric innovation and aims to provide scalable, next-generation solutions that can transform treatment paradigms [3] - Carisma is headquartered in Philadelphia, PA, and more information can be found on their website [3]